A Study to Demonstrate the Safety and Efficacy of Siplizumab in the Treatment of Hidradenitis Suppurativa

Conditions: Hidradenitis Suppurativa Interventions: Drug: Siplizumab Sponsors: University of Alabama at Birmingham; ITB-Med LLC Not yet recruiting

Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials